Erik Yusko

Erik Yusko

Company: Adaptive Biotechnologies

Job title: Senior Director of Drug Discovery


Adaptive’s ImmuneMedicine platform for TCR and neoAg discovery informs therapeutic development and patient monitoring 11:30 am

Adaptive’s core competency of sequencing and quantifying immune receptors at scale enables therapeutic discovery, development, and monitoring. High-throughput, scaled discovery of neoAg specific TCRs is neoAg discovery Discovery and quantification of Ag-specific, patient-specific TCRs enables informed monitoring of immune responses for vaccine development.Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.